Inhibition of tumor-intrinsic NAT10 enhances antitumor immunity by triggering type I interferon response via MYC/CDK2/DNMT1 pathway.

Although some immune cell populations in the sgNAT10 group demonstrated slightly increased infiltration compared to the WT group, these differences, with the exception of DCs, did not reach statistical significance.

also in 111,027 other papers